Altered Expression of Disintegrin Metalloproteinases and Their Inhibitor in Human Dilated Cardiomyopathy

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Circulation

• Publication date

  2006-01-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.105.571414PMID 16401770
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiac remodeling and failure: from molecules to man (Part III).

  2005cited by this paper
• Cardiac remodeling and failure: from molecules to man (Part I).

  2005cited by this paper
• TIMP-3 Deficiency Leads to Dilated Cardiomyopathy

  2004cited by this paper
• ADAM12 induces actin cytoskeleton and extracellular matrix reorganization during early adipocyte differentiation by regulating β1 integrin function

  2003cited by this paper
• Stress-activated cytokines and the heart: from adaptation to maladaptation.

  2003cited by this paper
• Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3.

  2003cited by this paper
• Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy

  2002cited by this paper
• Altered Expression of ADAMs (A D isintegrin A nd M etalloproteinase) in Fibrillating Human Atria

  2002cited by this paper
• Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective.

  2002cited by this paper
• Cardiac Myocyte-Specific Excision of the &bgr;1 Integrin Gene Results in Myocardial Fibrosis and Cardiac Failure

  2002cited by this paper
• Matrix metalloproteinases: regulation and dysregulation in the failing heart.

  2002cited by this paper
• Downregulation of Matrix Metalloproteinases and Reduction in Collagen Damage in the Failing Human Heart After Support With Left Ventricular Assist Devices

  2001cited by this paper
• The in vitro activity of ADAM‐10 is inhibited by TIMP‐1 and TIMP‐3

  2000cited by this paper
• ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3.

  2000cited by this paper
• Tumor Necrosis Factor-α–Converting Enzyme and Tumor Necrosis Factor-α in Human Dilated Cardiomyopathy

  1999cited by this paper
• Tumor necrosis factor-alpha-converting enzyme and tumor necrosis factor-alpha in human dilated cardiomyopathy.

  1999cited by this paper
• Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding.

  1999cited by this paper
• TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3

  1998cited by this paper
• TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3.

  1998cited by this paper
• A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.

  1997cited by this paper
• A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells

  1997cited by this paper
• Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy.

  1997cited by this paper

• Temporal inhibition of ADAM17 in fibroblasts reduces stiffness and promotes vascularization following myocardial infarction.

  2026cites this paper
• The emerging role of human transmembrane RGD-based counter-receptors of integrins in health and disease

  2025cites this paper
• Progress of ADAM17 in Fibrosis-Related Diseases

  2025cites this paper
• Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα–TRAF3–TAK1–MAPK axis

  2024cites this paper
• The protease ADAM17 at the crossroads of disease: revisiting its significance in inflammation, cancer, and beyond

  2023cites this paper
• Cardiomyocyte cohesion is increased after ADAM17 inhibition

  2023cites this paper
• Mapping cardiac remodeling in chronic kidney disease

  2023cites this paper
• The Role of ADAM17 in Inflammation-Related Atherosclerosis

  2022cites this paper
• ADAM17 knockdown mitigates while ADAM17 overexpression aggravates cardiac fibrosis and dysfunction via regulating ACE2 shedding and myofibroblast transformation

  2022cites this paper
• Role of ADAM and ADAMTS Disintegrin and Metalloproteinases in Normal Pregnancy and Preeclampsia.

  2022cites this paper
• Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice

  2022cites this paper
• Metabolic, fibrotic and splicing pathways are all altered in Emery-Dreifuss muscular dystrophy spectrum patients to differing degrees

  2022cites this paper
• Tissue Inhibitor of Metalloproteases 3 (TIMP-3): In Vivo Analysis Underpins Its Role as a Master Regulator of Ectodomain Shedding

  2022cites this paper
• ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.

  2022cites this paper
• Evidence for human diabetic cardiomyopathy

  2021cites this paper
• Meta-Analysis of Dilated Cardiomyopathy Using Cardiac RNA-Seq Transcriptomic Datasets

  2020cites this paper
• Soluble angiotensin converting enzyme 2 levels in chronic heart failure is associated with decreased exercise capacity and increased oxidative stress-mediated endothelial dysfunction.

  2019cites this paper
• Correlation between plasma-soluble angiotensin-converting enzyme 2, anti- angiotensin-converting enzyme 2, and angiotensin-(1–7) in patients with chronic heart failure

  2019influential citation
• A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.

  2019influential citation
• A Disintegrin and Metalloproteinase 12 prevents heart failure by regulating cardiac hypertrophy and fibrosis.

  2019cites this paper
• Role of matrix metalloproteinases and histone deacetylase in oxidative stress-induced degradation of the endothelial glycocalyx.

  2019cites this paper
• ADAM12 Controls a Hypertrophic Response in the Heart through the Distinct Descending Pathways.

  2019cites this paper
• Degradome of soluble ADAM10 and ADAM17 metalloproteases

  2019cites this paper
• Extracellular Matrix Macromolecules as Potential Targets of Cardiovascular Pharmacotherapy.

  2018cites this paper
• Disintegrin and metalloproteinases (ADAMs and ADAM-TSs), the emerging family of proteases in heart physiology and pathology

  2018cites this paper
• ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK‐AKT Signaling

  2018cites this paper
• The Notch Ligands DLL1 and Periostin Are Associated with Symptom Severity and Diastolic Function in Dilated Cardiomyopathy

  2017cites this paper
• Extracellular vesicles do not contribute to higher circulating levels of soluble LRP1 in idiopathic dilated cardiomyopathy

  2017cites this paper
• Role of blocking ADAM10 hydrolysis site on N-cadherin by single-chain antibody in ventricular remodeling

  2017cites this paper
• Measuring myokines with cardiovascular functions: pre-analytical variables affecting the analytical output.

  2017cites this paper
• Idiopathic Dilated Cardiomyopathy: Molecular Basis and Distilling Complexity to Advance

  2017cites this paper
• Mapping Heart Development in Flies: Src42A Acts Non-Autonomously to Promote Heart Tube Formation in Drosophila

  2017cites this paper
• ADAMs family and relatives in cardiovascular physiology and pathology.

  2016cites this paper
• ADAM12‐deficient zebrafish exhibit retardation in body growth at the juvenile stage without developmental defects

  2016cites this paper
• Global phosphoproteomic profiling reveals perturbed signaling in a mouse model of dilated cardiomyopathy

  2016cites this paper
• Differential impact of mechanical unloading on structural and nonstructural components of the extracellular matrix in advanced human heart failure.

  2016cites this paper
• Enhanced ADAM17 expression is associated with cardiac remodeling in rats with acute myocardial infarction.

  2016cites this paper
• Expression of ADAM17 and ADAM10 in nasal polyps

  2016cites this paper
• Characterisation of ADAM15-mediated changes to cellular behaviour in breast cancer cells

  2016cites this paper
• A Disintegrin and Metalloprotease-17 Regulates Pressure Overload–Induced Myocardial Hypertrophy and Dysfunction Through Proteolytic Processing of Integrin &bgr;1

  2016cites this paper
• Extracellular Matrix and Cardiac Disease: Surgical and Scientific Perspectives

  2015cites this paper
• Aging-related Changes in Cardiac Extracellular Matrix: Implications for Heart Failure in Older Patients

  2015cites this paper
• Cardiomyocyte A Disintegrin And Metalloproteinase 17 (ADAM17) Is Essential in Post–Myocardial Infarction Repair by Regulating Angiogenesis

  2015cites this paper
• ADAM17 Promotes Motility, Invasion, and Sprouting of Lymphatic Endothelial Cells

  2015cites this paper
• Rôle de ADAM12 dans la Transition Epithélio-Mésenchymateuse

  2015cites this paper
• Vitamin D, ADAM-12 and Carotid Artery Disease

  2015cites this paper
• Genes Mediating Cardiac Remodeling During Pregnancy and the Early Post-Partum-Period in Mice

  2014cites this paper
• Inverse relationship between raft LRP1 localization and non-raft ERK1,2/MMP9 activation in idiopathic dilated cardiomyopathy: potential impact in ventricular remodeling.

  2014cites this paper
• Acetylsalicylic Acid Inhibits IL‐18‐Induced Cardiac Fibroblast Migration Through the Induction of RECK

  2014cites this paper
• Expression of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial infarction.

  2014cites this paper
• Maternal Bisphenol A Exposure Impacts the Fetal Heart Transcriptome

  2014cites this paper
• Proteases as Potential Targets in Left Ventricular Remodeling After Myocardial Infarction

  2014cites this paper
• A Disintegrin and Metalloproteinase-12 as a New Target for Cancer Treatment

  2014cites this paper
• Proteases as Clinical Markers of Adverse Remodeling for Heart Failure in the Aging Population

  2014cites this paper
• Cardiac matrix remodeling and heart failure

  2014cites this paper
• The use of MMP2 antibody-conjugated cationic microbubble to target the ischemic myocardium, enhance Timp3 gene transfection and improve cardiac function.

  2014cites this paper
• Attenuation of increased secretory leukocyte protease inhibitor, matricellular proteins and angiotensin II and left ventricular remodeling by candesartan and omapatrilat during healing after reperfused myocardial infarction

  2013cites this paper
• Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK.

  2013cites this paper
• Serum levels of ADAM12‐S: possible association with the initiation and progression of dermal fibrosis and interstitial lung disease in patients with systemic sclerosis

  2013cites this paper
• Bioresponsive molecular imaging probes

  2012cites this paper
• Cardiac structural and hemodynamic changes associated with physiological heart hypertrophy of pregnancy are reversed postpartum.

  2012cites this paper
• Lipopolysaccharide regulates MMP-9 expression through TLR4/NF-κB signaling in human arterial smooth muscle cells.

  2012cites this paper
• Reverse right ventricular structural and extracellular matrix remodeling by estrogen in severe pulmonary hypertension.

  2012cites this paper
• Une désintégrine et métalloprotéase 12 (ADAM12)

  2012cites this paper
• Association of ADAM12-S protein with radiographic features of knee osteoarthritis and bone and cartilage markers

  2012cites this paper
• Review Article New frontiers in heart hypertrophy during pregnancy

  2012cites this paper
• Activation of a-secretases : a novel therapeutic strategy for the treatment of traumatic brain injury ; L'activation des α-sécrétases : une nouvelle stratégie thérapeutique pour le traitement du traumatisme crânien

  2012cites this paper
• (cid:1) 1 Integrin Gene Excision in the Adult Murine Cardiac Myocyte Causes Defective Mechanical and Signaling Responses

  2012cites this paper
• New frontiers in heart hypertrophy during pregnancy.

  2012cites this paper
• Insights into the Activity, Differential Expression, Mutual Regulation, and Functions of Matrix Metalloproteinases and A Disintegrin and Metalloproteinases in Hypertension and Cardiac Disease

  2012cites this paper
• Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications

  2012cites this paper
• Complex patterns of ADAM12 mRNA and protein splice variants in the human placenta.

  2011cites this paper
• Aberrant Expression of Disintegrin-Metalloprotease Proteins in the Formation and Progression of Uterine Cervical Cancer

  2011cites this paper
• Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency.

  2011cites this paper
• Active metalloproteases of the A Disintegrin and Metalloprotease (ADAM) family: biological function and structure.

  2011cites this paper
• The quantification of ADAMTS4 and 8 expression and selection of reference genes for quantitative real-time PCR analysis in myocardial infarction.

  2011cites this paper
• Loss of protease activity of ADAM15 abolishes protective effects on plaque progression in atherosclerosis.

  2011cites this paper
• Unloading the infarcted heart affect MMPs–TIMPs axis in a rat cardiac heterotopic transplantation model

  2011cites this paper
• Biofeedback in the treatment of heart failure

  2010cites this paper
• Aging-Related Early Changes in Markers of Ventricular and Matrix Remodeling After Reperfused ST-Segment Elevation Myocardial Infarction in the Canine Model: Effect of Early Therapy With an Angiotensin II Type 1 Receptor Blocker

  2010cites this paper
• Renin angiotensin system and cardiovascular disease

  2010cites this paper
• Novel neurohormonal insights with therapeutic potential in chronic heart failure.

  2010cites this paper
• The Role of SnoN in Transforming Growth Factor β1-induced Expression of Metalloprotease-Disintegrin ADAM12*

  2010cites this paper
• Matrix Metalloproteinase-7 and ADAM-12 (a Disintegrin and Metalloproteinase-12) Define a Signaling Axis in Agonist-Induced Hypertension and Cardiac Hypertrophy

  2009cites this paper
• Molecular and cellular characterization of cardiac overload-induced hypertrophy and failure

  2009cites this paper
• l'athérosclérose et l'obésité

  2009cites this paper
• Regulation and proteolytic activity of ADAM12 metalloprotease

  2009cites this paper
• Angiotensin-(1-7), Angiotensin-Converting Enzyme 2, and New Components of the Renin Angiotensin System

  2009cites this paper
• Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes.

  2009cites this paper
• [The two sides of ADAM17 in inflammation: implications in atherosclerosis and obesity].

  2009cites this paper
• General and Outline of the Thesis

  2009cites this paper
• Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient mice.

  2009cites this paper
• Tumor Necrosis Factor- –Converting Enzyme Is a Key Regulator of Agonist-Induced Cardiac Hypertrophy and Fibrosis

  2009cites this paper
• Expression of ADAM‐15 in rat myocardial infarction

  2009influential citation
• Targeting ADAM12 in human disease: head, body or tail?

  2009cites this paper
• Soluble Tie 2: Mechanisms of Regulation and Role in Modulating Angiogenesis

  2009cites this paper
• The role of integrin-mediated cell adhesion in atherosclerosis: pathophysiology and clinical opportunities.

  2008cites this paper
• Extracellular matrix profiles in the progression to heart failure

  2008cites this paper
• Gene and protein expression changes in response to normoxic perfusion in mouse hearts.

  2008cites this paper
• Cellular roles of ADAM12 in health and disease.

  2008cites this paper